Method of treating neurodegenerative disease

Details for Australian Patent Application No. 2004255557 (hide)

Owner Alnylam Pharmaceuticals, Inc. Mayo Foundation for Medical Education and Research

Inventors Bumcrot, David; Maraganore, Demetrius; Farrer, Matthew J.; Vornlocher, Hans-Peter

Agent Griffith Hack

Pub. Number AU-B-2004255557

PCT Pub. Number WO2005/004794

Priority 60/476,947 09.06.03 US

Filing date 9 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 10 June 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/004794 Priority application(s): WO2005/004794

10 June 2010 Application Accepted

  Published as AU-B-2004255557

7 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255562-Method for making hydrogen using a gold containing water-gas shift catalyst

2004255553-Compositions and methods for treating coagulation related disorders